WO2007135293A3 - 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur préparation, compositions les contenant et utilisation - Google Patents

2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur préparation, compositions les contenant et utilisation Download PDF

Info

Publication number
WO2007135293A3
WO2007135293A3 PCT/FR2007/000866 FR2007000866W WO2007135293A3 WO 2007135293 A3 WO2007135293 A3 WO 2007135293A3 FR 2007000866 W FR2007000866 W FR 2007000866W WO 2007135293 A3 WO2007135293 A3 WO 2007135293A3
Authority
WO
WIPO (PCT)
Prior art keywords
benzazepines
alkylamide
trihydroxy
alkoxy
preparation
Prior art date
Application number
PCT/FR2007/000866
Other languages
English (en)
Other versions
WO2007135293A2 (fr
Inventor
Jidong Zhang
Frederico Nardi
Alain Commercon
Original Assignee
Sanofi Aventis
Jidong Zhang
Frederico Nardi
Alain Commercon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP07765942A priority Critical patent/EP2035387A2/fr
Priority to CA002649336A priority patent/CA2649336A1/fr
Priority to EA200870565A priority patent/EA200870565A1/ru
Priority to MX2008014844A priority patent/MX2008014844A/es
Priority to JP2009511545A priority patent/JP2009537614A/ja
Priority to AU2007253196A priority patent/AU2007253196A1/en
Priority to BRPI0712925-4A priority patent/BRPI0712925A2/pt
Application filed by Sanofi Aventis, Jidong Zhang, Frederico Nardi, Alain Commercon filed Critical Sanofi Aventis
Publication of WO2007135293A2 publication Critical patent/WO2007135293A2/fr
Publication of WO2007135293A3 publication Critical patent/WO2007135293A3/fr
Priority to TNP2008000402A priority patent/TNSN08402A1/en
Priority to IL195148A priority patent/IL195148A0/en
Priority to US12/267,689 priority patent/US7994162B2/en
Priority to EC2008008893A priority patent/ECSP088893A/es
Priority to NO20085285A priority patent/NO20085285L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Abstract

La présente invention concerne notamment des 2-alcoxy-3,4,5-trihydroxy- alkylamide-benzazépines, leur préparation, des compositions les contenant, et leur utilisation comme médicament, en particulier en tant qu'agents anticancéreux. Formule (I).
PCT/FR2007/000866 2006-05-24 2007-05-23 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur préparation, compositions les contenant et utilisation WO2007135293A2 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
AU2007253196A AU2007253196A1 (en) 2006-05-24 2007-05-23 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same
CA002649336A CA2649336A1 (fr) 2006-05-24 2007-05-23 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation
EA200870565A EA200870565A1 (ru) 2006-05-24 2007-05-23 2-алкокси-3,4,5-тригидроксиалкиламидобензазепины, их получение, содержащие их композиции и применение
MX2008014844A MX2008014844A (es) 2006-05-24 2007-05-23 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzazepina, su preparacion, composiciones que las contienen y utilizacion.
JP2009511545A JP2009537614A (ja) 2006-05-24 2007-05-23 ２−アルコキシ−３，４，５−トリヒドロキシ−アルキルアミド−ベンズアゼピン、これの調製およびこれの使用ならびにこれを含有する組成物
EP07765942A EP2035387A2 (fr) 2006-05-24 2007-05-23 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur préparation, compositions les contenant et utilisation
BRPI0712925-4A BRPI0712925A2 (pt) 2006-05-24 2007-05-23 2-alcàxi-3,4,5-triidràxi-alquilamida-benzazepina, sua preparaÇço, composiÇÕes que as contÊm, e utilizaÇço
TNP2008000402A TNSN08402A1 (en) 2006-05-24 2008-10-15 Modular system for realising furnishing elements
IL195148A IL195148A0 (en) 2006-05-24 2008-11-06 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof and compositions containing the same
US12/267,689 US7994162B2 (en) 2006-05-24 2008-11-10 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same
EC2008008893A ECSP088893A (es) 2006-05-24 2008-11-17 2-alcoxi-3, 4,5-trihidroxi-alquilamida-benzazepinas, su preparación, composiciones que las contienen y utilización
NO20085285A NO20085285L (no) 2006-05-24 2008-12-17 2-alkosy-3,4,5-tnhydroksyalkylamidbenzazepiner, deres fremstilling og bruk samt preparater inneholdende disse

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0604733A FR2901554B1 (fr) 2006-05-24 2006-05-24 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation
FR0604733 2006-05-24

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/267,689 Continuation US7994162B2 (en) 2006-05-24 2008-11-10 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same

Publications (2)

Publication Number Publication Date
WO2007135293A2 WO2007135293A2 (fr) 2007-11-29
WO2007135293A3 true WO2007135293A3 (fr) 2008-05-02

Family

ID=37487536

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2007/000866 WO2007135293A2 (fr) 2006-05-24 2007-05-23 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur préparation, compositions les contenant et utilisation

Country Status (24)

Country Link
US (1) US7994162B2 (fr)
EP (1) EP2035387A2 (fr)
JP (1) JP2009537614A (fr)
KR (1) KR20090010071A (fr)
CN (1) CN101454290A (fr)
AR (1) AR061103A1 (fr)
AU (1) AU2007253196A1 (fr)
BR (1) BRPI0712925A2 (fr)
CA (1) CA2649336A1 (fr)
CR (1) CR10382A (fr)
DO (1) DOP2007000104A (fr)
EA (1) EA200870565A1 (fr)
EC (1) ECSP088893A (fr)
FR (1) FR2901554B1 (fr)
GT (1) GT200800249A (fr)
IL (2) IL194972A0 (fr)
MA (1) MA30561B1 (fr)
MX (1) MX2008014844A (fr)
NO (1) NO20085285L (fr)
PE (1) PE20080705A1 (fr)
TN (1) TNSN08402A1 (fr)
TW (1) TW200812971A (fr)
UY (1) UY30368A1 (fr)
WO (1) WO2007135293A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2878528B1 (fr) 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
CN102924462B (zh) * 2012-10-24 2015-01-14 华东师范大学 1,2,3,4,5,9-取代苯并吖庚因类化合物的合成方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692522A (en) * 1985-04-01 1987-09-08 Merck & Co., Inc. Benzofused lactams useful as cholecystokinin antagonists
WO2001085697A1 (fr) * 2000-05-11 2001-11-15 Novartis Ag Carbonates et ethers de caprolactame substitues et utilisation de ceux-ci comme agents anti tumoraux
WO2005014574A1 (fr) * 2003-07-25 2005-02-17 Novartis Ag Lactames substitues et utilisation de ceux-ci en tant qu'agents anti-cancereux
WO2006056696A2 (fr) * 2004-11-29 2006-06-01 Aventis Pharma S.A. 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831135A (en) 1986-06-18 1989-05-16 The Regents Of The University Of California Bengamide anthelmintics
US5283241A (en) 1992-08-28 1994-02-01 Merck & Co., Inc. Benzo-fused lactams promote release of growth hormone
GB9411841D0 (en) 1994-06-14 1994-08-03 Pharma Mar Sa New antitumoral compounds from jaspis sponge
JP2002241368A (ja) 1997-02-18 2002-08-28 Shionogi & Co Ltd 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
US6239127B1 (en) 1999-11-17 2001-05-29 Novartis Ag Certain substituted caprolactams, pharmaceutical compositions containing them and a process for their preparation
CO5140099A1 (es) 1998-11-17 2002-03-22 Novartis Ag Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores
JP2004514122A (ja) 2000-11-14 2004-05-13 ノバルティス　アクチエンゲゼルシャフト 抗増殖性化合物をスクリーニングしかつ腫瘍増殖を阻害する方法
US6545148B2 (en) 2001-03-12 2003-04-08 Novartis Ag Process for preparing certain substituted caprolactams
JP2004262793A (ja) 2003-02-28 2004-09-24 Noyaku Bio Technology Kaihatsu Gijutsu Kenkyu Kumiai 化合物ｎ−９０１１、その製造法及び用途
US7153846B2 (en) 2003-10-24 2006-12-26 Sanofi-Aventis Deutschland Gmbh Bengamide derivatives, process for preparing them, and their use
DE10349669B3 (de) 2003-10-24 2005-05-25 Aventis Pharma Deutschland Gmbh Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2878525B1 (fr) 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692522A (en) * 1985-04-01 1987-09-08 Merck & Co., Inc. Benzofused lactams useful as cholecystokinin antagonists
WO2001085697A1 (fr) * 2000-05-11 2001-11-15 Novartis Ag Carbonates et ethers de caprolactame substitues et utilisation de ceux-ci comme agents anti tumoraux
WO2005014574A1 (fr) * 2003-07-25 2005-02-17 Novartis Ag Lactames substitues et utilisation de ceux-ci en tant qu'agents anti-cancereux
WO2006056696A2 (fr) * 2004-11-29 2006-06-01 Aventis Pharma S.A. 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ADAMCZESKI M ET AL: "Novel Sponge-Derived Amino Acids. 5. Structures, Stereochemistry, and Synthesis of Several New Heterocycles", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 111, no. 2, 1989, pages 647 - 654, XP002171012, ISSN: 0002-7863 *
CHANG C-Y ET AL: "Synthesis of optically active alpha-aminobenzolactam via an oxidative-cyclization reaction", TETRAHEDRON: ASYMMETRY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 14, no. 14, 18 July 2003 (2003-07-18), pages 2081 - 2085, XP004435224, ISSN: 0957-4166 *
KINDER F R ET AL: "Synthesis and antitumour activity of ester modified analogues of bengamide B", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 44, 2001, pages 3692 - 3699, XP002311636, ISSN: 0022-2623 *
PARSONS ET AL.: "Cholecystokinin Antagonists. Synthesis and Biological Evaluation of 3-Substituted Benzolactams", J. MED. CHEM., vol. 32, no. 8, 1989, pages 1681 - 1685, XP002457489 *
RAMANA ET AL.: "A Carbohydrate-Based Approach for the Total Synthesis of 1,3-Polyol/alpha-Pyrone Antifungal Natural Products", J. ORG. CHEM., vol. 70, 2005, pages 8216 - 8219, XP002411409 *
THALE Z ET AL: "BENGAMIDES REVISITED: NEW STRUCTURES AND ANTITUMOR STUDIES", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, vol. 66, 2001, pages 1733 - 1741, XP002310387, ISSN: 0022-3263 *

Also Published As

Publication number Publication date
NO20085285L (no) 2008-12-17
EA200870565A1 (ru) 2009-06-30
US7994162B2 (en) 2011-08-09
MA30561B1 (fr) 2009-07-01
CA2649336A1 (fr) 2007-11-29
JP2009537614A (ja) 2009-10-29
IL195148A0 (en) 2009-09-22
EP2035387A2 (fr) 2009-03-18
US20090099152A1 (en) 2009-04-16
MX2008014844A (es) 2009-02-17
FR2901554B1 (fr) 2011-04-01
ECSP088893A (es) 2008-12-30
UY30368A1 (es) 2008-01-02
IL194972A0 (en) 2009-08-03
GT200800249A (es) 2009-05-15
BRPI0712925A2 (pt) 2013-01-08
WO2007135293A2 (fr) 2007-11-29
DOP2007000104A (es) 2007-11-15
FR2901554A1 (fr) 2007-11-30
TNSN08402A1 (en) 2010-04-14
TW200812971A (en) 2008-03-16
AU2007253196A1 (en) 2007-11-29
PE20080705A1 (es) 2008-07-30
CR10382A (es) 2009-02-26
CN101454290A (zh) 2009-06-10
KR20090010071A (ko) 2009-01-28
AR061103A1 (es) 2008-08-06

Similar Documents

Publication Publication Date Title
WO2007090393A3 (fr) Préparation pharmaceutique
WO2006114520A3 (fr) Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
WO2008006528A3 (fr) Nouvelles compositions pharmaceutiques comprenant du lévétiracétam
IL195488A (en) Compounds, pharmaceuticals containing them and their uses
WO2007065595A3 (fr) Derives de la xanthine, procedes de preparation et utilisations de ceux-ci
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
TNSN08321A1 (en) Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
TW200738627A (en) Trialkylsilyl-indoles
WO2006097617A3 (fr) Nouveaux derives dihydropyrimidines et leur utilisation comme agents anti-cancereux
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
WO2006134021A3 (fr) Procede de preparation de nouveaux sels de tiotropium, nouveaux sels de tiotropium en tant que tels et compositions pharmaceutiques associees
WO2006133006A3 (fr) 1-methyl-1h-pyrazole-4-carboxamides utiles comme agents chimiotherapeutiques anticancereux
WO2008073863A3 (fr) Préparation et utilité d'allylamines substituées
WO2007087026A3 (fr) Forme solide de amg 706 et compositions pharmaceutiques contenant ledit composé
WO2006128847A3 (fr) Nouvelles combinaisons medicamenteuses pour le traitement de maladies respiratoires
WO2007018941A3 (fr) Composes
CA2725949A1 (fr) Nouveaux composes v
WO2006055663A3 (fr) Nouvelle utilisation
GB0615105D0 (en) Novel compounds
WO2008070354A3 (fr) Benzidimidazole thiophènes substitués en 5 et 6 pour plk
WO2007135293A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur préparation, compositions les contenant et utilisation
WO2007135295A3 (fr) Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur préparation, compositions les contenant et utilisation
TNSN08242A1 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
WO2007135294A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur préparation, compositions les contenant et utilisation
WO2006023707A3 (fr) Utilisation de 2-aminothiophenecarboxamides comme agents chimiotherapeutiques dans le traitement du cancer

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780018996.7

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07765942

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: DZP2008000598

Country of ref document: DZ

WWE Wipo information: entry into national phase

Ref document number: 2649336

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: CR2008-010382

Country of ref document: CR

WWE Wipo information: entry into national phase

Ref document number: 2007765942

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 194972

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 572371

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 4392/KOLNP/2008

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2007253196

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 12008502468

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 2008111874

Country of ref document: EG

WWE Wipo information: entry into national phase

Ref document number: 2009511545

Country of ref document: JP

Ref document number: MX/A/2008/014844

Country of ref document: MX

Ref document number: 1020087028521

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 08124869

Country of ref document: CO

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2007253196

Country of ref document: AU

Date of ref document: 20070523

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 200870565

Country of ref document: EA

ENP Entry into the national phase

Ref document number: PI0712925

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20081124